Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat. (Q42498874)

1 November 2017

Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat. (English)

1 reference

1 November 2017

Yamaguchi Y

1

1 reference

PubMed ID

11166290

1 November 2017

Kawashima S

series ordinal

2

1 reference

PubMed ID

11166290

1 November 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

European Journal of Pharmacology

1 November 2017

1 reference

1 November 2017

412

1 reference

1 November 2017

3

1 reference

1 November 2017

265-272

1 reference

Administration of amyloid beta-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo.

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

The septal forebrain and the inhibitory modulation of attack and defense in the rat. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

The cholinergic hypothesis of geriatric memory dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Neuropathology of synthetic beta-amyloid peptide analogs in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

The septohippocampal pathway: structure and function of a central cholinergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

A rapid radiochemical method for the determination of choline acetyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Comparison between the behavioural effects of septal and hippocampal lesions: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Beta-amyloid(Phe(SO3H)24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

N-Methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against beta-amyloid neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein--infused rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Qualitative abnormalities of choline acetyltransferase in Alzheimer type dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Amyloid plaque core protein in Alzheimer disease and Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

beta-Amyloid protein-induced Alzheimer's disease animal model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Remembrance of places passed: Spatial memory in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Repeated intracerebroventricular administration of beta-amyloid(25-35) to rats decreases muscarinic receptors in cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

The molecular pathology of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Intrahippocampal injections of exogenous beta-amyloid induce postdelay errors in an eight-arm radial maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900730-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)00730-0

1 reference

1 November 2017

1 reference

PubMed ID

11166290